Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

NCT03958955 PHASE2 TERMINATED Results posted

This was a double-blind, multi-centre, randomised, vehicle-controlled, within-subject phase 2a trial. The trial was designed to establish the efficacy and safety of delgocitinib cream in the treatment of adult subjects with discoid lupus erythematosus (DLE).

Details

Lead sponsor	LEO Pharma
Phase	PHASE2
Status	TERMINATED
Enrolment	27
Start date	Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Apr 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Discoid Lupus Erythematosus

Interventions

• Delgocitinib cream
• Delgocitinib cream vehicle

Countries

Denmark, France, United States, Germany